"The scientists aimed to uncover cellular interactions between super-enhancers and lncRNAs by studying RNA sequencing data from patients with metastatic castration-resistant prostate cancer."
"Through computational analysis and gene knock-down experiments, the scientists discovered that IGF1R-AS1 is expressed solely in tumor tissue and not in normal healthy tissue."
"IGF1R-AS1 directly interacts with chromatin remodeling complexes that regulate chromatin structure and gene expression, as well as architectural proteins."
"The study identified a total of 1,344 lncRNAs, with IGF1R-AS1 demonstrating the strongest association with super-enhancers."
Scientists discovered that the long non-coding RNA IGF1R-AS1 activates oncogenic signaling pathways in prostate cancer cells, driving tumor progression. This RNA is expressed only in tumor tissue and is overexpressed in prostate and lung cancer cells. The study identified 1,344 lncRNAs and found that IGF1R-AS1 interacts with chromatin remodeling complexes and architectural proteins, influencing gene expression. These findings underscore the potential of IGF1R-AS1 as a therapeutic target in cancer treatment.
Read at News Center
Unable to calculate read time
Collection
[
|
...
]